Skip to contents

Header Skipped.

Division of Pharmacoepidemiology and Pharmacoecomonics

The appropriate use of medications is a central aspect of health care. Each year, basic science research and biotechnology produce new treatments which hold the promise of major clinical benefit. However, these interventions also carry risks which must be rigorously measured and evaluated against the treatment's efficacy.  Drugs are also a growing component of health care expenditures, and more attention is being drawn to the relation between the costs of medication and their benefits.

In 1998, the BWH Department of Medicine created the Division of Pharmacoepidemiology and Pharmacoeconomics to facilitate a wide range of activities related to the use and outcomes of medications, addressed from a variety of interdisciplinary perspectives. Its mission is to bring together the various specialties of medicine, epidemiology, biostatistics, health services research, and the social sciences to evaluate the effectiveness of existing and new prescription drugs in relation to their risks and costs; to study how medications are used by physicians and patients; and to develop methods to optimize prescription drug use.

Please visit our website at DrugEpi.org

Video welcome message from Jerome L. Avorn, MD, Chief of the Division of Pharmacoepidemiology and Pharmacoecomonics.

LEARN MORE ABOUT BRIGHAM AND WOMEN’S HOSPITAL


For over a century, a leader in patient care, medical education and research, with expertise in virtually every specialty of medicine and surgery.

About BWH